Skip to main content

Main menu

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI

User menu

  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Journal of Nuclear Medicine
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Journal of Nuclear Medicine

Advanced Search

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • View or Listen to JNM Podcast
  • Visit JNM on Facebook
  • Join JNM on LinkedIn
  • Follow JNM on Twitter
  • Subscribe to our RSS feeds
OtherClinical Investigations (Human)

Cerebellum can serve as a pseudo-reference region in Alzheimer’s disease to detect neuroinflammation measured with PET radioligand binding to translocator protein (TSPO)

Chul Hyoung Lyoo, Masamichi Ikawa, Jeih-San Liow, Sami S. Zoghbi, Cheryl Morse, Victor W Pike, Masahiro Fujita, Robert B. Innis and William C. Kreisl
Journal of Nuclear Medicine March 2015, jnumed.114.146027; DOI: https://doi.org/10.2967/jnumed.114.146027
Chul Hyoung Lyoo
1 Gangnam Severance Hospital, NIMH/NIH;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Masamichi Ikawa
2 NIMH/NIH;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Jeih-San Liow
2 NIMH/NIH;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Sami S. Zoghbi
2 NIMH/NIH;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Cheryl Morse
2 NIMH/NIH;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Victor W Pike
2 NIMH/NIH;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Masahiro Fujita
2 NIMH/NIH;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Robert B. Innis
2 NIMH/NIH;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
William C. Kreisl
3 Taub Institute, Columbia University Medical Center
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Supplemental
  • Info & Metrics
  • PDF
Loading

Abstract

Alzheimer’s disease (AD) is associated with increase in brain of the 18 kDa translocator protein (TSPO), which is over-expressed in activated microglia and reactive astrocytes. Measuring the density of TSPO with PET typically requires absolute quantitation with arterial blood sampling, because a reference region devoid of TSPO does not exist in brain. We sought to determine whether a simple ratio method could substitute for absolute quantitation of binding with 11C-PBR28, a second generation radioligand for TSPO. Methods: 11C-PBR28 PET imaging was performed in 21 healthy controls, 11 individuals with mild cognitive impairment (MCI), and 25 AD patients. Group differences in 11C-PBR28 binding were compared using two methods. First, the “gold standard” method of calculating total distribution volume (VT), using the two-tissue compartmental model with the arterial input function, corrected for plasma free fraction of radiotracer (fP). Second, a ratio of brain uptake in target regions to that in cerebellum—i.e., standardized uptake value ratio (SUVR). Results: Using absolute quantitation, we confirmed that TSPO binding (VT/fP): 1) was greater in AD patients than in healthy controls in expected temporo-parietal regions, and 2) was not significantly different among the three groups in cerebellum. Using the cerebellum as a pseudo-reference region, the SUVR method detected greater binding in AD patients than controls in the same regions as absolute quantification and in one additional region, suggesting SUVR may have greater sensitivity. Coefficients of variation of SUVR measurements were about two-thirds lower than those of absolute quantification, and the resulting statistical significance was much higher for SUVR when comparing AD and healthy controls (e.g. P < 0.0005 for SUVR vs. P = 0.023 for VT/fP in combined middle and inferior temporal cortex). Conclusion: To measure TSPO density in AD and control subjects, a simple ratio method SUVR can substitute for, and may even be more sensitive than, absolute quantitation. The SUVR method is expected to improve subject tolerability by allowing shorter scan time and not requiring arterial catheterization. In addition, this ratio method allows smaller sample sizes for comparable statistical significance because of the relatively low variability of the ratio values.

  • Image Processing
  • Neurology
  • PET
  • <sup>11</sup>C-PBR28
  • Alzheimer’s disease
  • neuroinflammation
  • positron emission tomography
  • ratio method
  • Copyright © 2015 by the Society of Nuclear Medicine and Molecular Imaging, Inc.
Next
Back to top

In this issue

Journal of Nuclear Medicine: 66 (5)
Journal of Nuclear Medicine
Vol. 66, Issue 5
May 1, 2025
  • Table of Contents
  • Table of Contents (PDF)
  • About the Cover
  • Index by author
  • Complete Issue (PDF)
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on Journal of Nuclear Medicine.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Cerebellum can serve as a pseudo-reference region in Alzheimer’s disease to detect neuroinflammation measured with PET radioligand binding to translocator protein (TSPO)
(Your Name) has sent you a message from Journal of Nuclear Medicine
(Your Name) thought you would like to see the Journal of Nuclear Medicine web site.
Citation Tools
Cerebellum can serve as a pseudo-reference region in Alzheimer’s disease to detect neuroinflammation measured with PET radioligand binding to translocator protein (TSPO)
Chul Hyoung Lyoo, Masamichi Ikawa, Jeih-San Liow, Sami S. Zoghbi, Cheryl Morse, Victor W Pike, Masahiro Fujita, Robert B. Innis, William C. Kreisl
Journal of Nuclear Medicine Mar 2015, jnumed.114.146027; DOI: 10.2967/jnumed.114.146027

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
Cerebellum can serve as a pseudo-reference region in Alzheimer’s disease to detect neuroinflammation measured with PET radioligand binding to translocator protein (TSPO)
Chul Hyoung Lyoo, Masamichi Ikawa, Jeih-San Liow, Sami S. Zoghbi, Cheryl Morse, Victor W Pike, Masahiro Fujita, Robert B. Innis, William C. Kreisl
Journal of Nuclear Medicine Mar 2015, jnumed.114.146027; DOI: 10.2967/jnumed.114.146027
Twitter logo Facebook logo LinkedIn logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One
Bookmark this article

Jump to section

  • Article
  • Figures & Data
  • Supplemental
  • Info & Metrics
  • PDF

Related Articles

  • This Month in JNM
  • PubMed
  • Google Scholar

Cited By...

  • [11C]PS13 Demonstrates Pharmacologically Selective and Substantial Binding to Cyclooxygenase-1 in the Human Brain
  • Remote Neuroinflammation in Newly Diagnosed Glioblastoma Correlates with Unfavorable Clinical Outcome
  • [18F]DPA-714 PET Imaging in the Presurgical Evaluation of Patients With Drug-Resistant Focal Epilepsy
  • Individual regional associations between A{beta}-, tau- and neurodegeneration (ATN) with microglial activation in patients with primary and secondary tauopathies
  • [18F]ROStrace detects oxidative stress in vivo and predicts progression of Alzheimers disease pathology in APP/PS1 mice
  • Mitochondrial control of microglial phagocytosis in Alzheimers disease
  • Microglia Activation in Basal Ganglia Is a Late Event in Huntington Disease Pathophysiology
  • Association of Early {beta}-Amyloid Accumulation and Neuroinflammation Measured With [11C]PBR28 in Elderly Individuals Without Dementia
  • Olfactory impairment is related to tau pathology and neuroinflammation in Alzheimers disease
  • Moving Toward Multicenter Therapeutic Trials in Amyotrophic Lateral Sclerosis: Feasibility of Data Pooling Using Different Translocator Protein PET Radioligands
  • Regional protein expression in human Alzheimers brain correlates with disease severity
  • Automatic Extraction of a Reference Region for the Noninvasive Quantification of Translocator Protein in Brain Using 11C-PBR28
  • We need to talk about reliability: Making better use of test-retest studies for study design and interpretation
  • Head-to-Head Comparison of 11C-PBR28 and 18F-GE180 for Quantification of the Translocator Protein in the Human Brain
  • Neuroinflammation Appears Early on PET Imaging and Then Plateaus in a Mouse Model of Alzheimer Disease
  • Pseudoreference Regions for Glial Imaging with 11C-PBR28: Investigation in 2 Clinical Cohorts
  • The 5-HT1A Receptor PET Radioligand 11C-CUMI-101 Has Significant Binding to {alpha}1-Adrenoceptors in Human Cerebellum, Limiting Its Use as a Reference Region
  • Parametric Binding Images of the TSPO Ligand 18F-DPA-714
  • Glial Activation and Glucose Metabolism in a Transgenic Amyloid Mouse Model: A Triple-Tracer PET Study
  • Imaging Microglial Activation with TSPO PET: Lighting Up Neurologic Diseases?
  • Google Scholar

More in this TOC Section

Clinical Investigations (Human)

  • The added value of 18F-FDG PET/CT compared to 68Ga-PSMA PET/CT in patients with castration-resistant prostate cancer
Show more Clinical Investigations (Human)

Clinical (Neurology)

  • Predicting the Outcome of Epilepsy Surgery by Covariance Pattern Analysis of Ictal Perfusion SPECT
  • Postinfectious Neurologic Complications in COVID-19: A Complex Case Report
Show more Clinical (Neurology)

Similar Articles

Keywords

  • Image Processing
  • Neurology
  • PET
  • <sup>11</sup>C-PBR28
  • Alzheimer’s disease
  • neuroinflammation
  • Positron Emission Tomography
  • ratio method
SNMMI

© 2025 SNMMI

Powered by HighWire